Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

ELDNELDN
Showing 8 of 23 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in ELEDON PHARMACEUTICALS INC

Ensign Peak Advisors, Inc holds 2.1M shares of ELDN (ELEDON PHARMACEUTICALS INC), worth $8.3M as of 2026-Q2. The position was decreased (-14.8% shares). ELDN represents 0.0% of Ensign Peak Advisors, Inc's portfolio.

Current Value

$8.3M

Current Shares

2.1M

Total Value Change

+$7.2M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.1M
-14.8%
$8.3M0.0%$3.94
0
2026-Q1
Unchanged
2.5M
0.0%
$7.6M0.0%$2.50
0
2025-Q4
Increased
2.5M
+94.9%
$3.7M0.0%$1.51
42
2025-Q3
Unchanged
1.3M
0.0%
$3.3M0.0%$2.54
0
2025-Q2
Unchanged
1.3M
0.0%
$3.4M0.0%$2.69
0
2025-Q1
Unchanged
1.3M
0.0%
$4.3M0.0%$3.35
0
2024-Q4
Increased
1.3M
+185.5%
$5.2M0.0%$4.14
44
2024-Q3
Unchanged
443,001
0.0%
$1.1M0.0%$2.49
0

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used